Franck Suzenet

Prof. Dr. Franck Suzenet

orcid

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 January 2012 in Inorganic Chemistry
Verified
Journal Article
Closed access
FCFabien Caillé
Fabien Caillé
Célia S.  BonnetCélia S. Bonnet
Célia S. Bonnet
FBFrédéric Buron
Frédéric Buron
SVSandrine Villette
Sandrine Villette
LHLothar Helm
Lothar Helm
ÉTÉva Tóth
Éva Tóth

19 October 2009 in Organic Letters
Verified
Journal Article
Closed access
MJMatthieu Jeanty
Matthieu Jeanty
JBJérôme Blu
Jérôme Blu
FSFranck Suzenet
Franck Suzenet
GGGérald Guillaumet
Gérald Guillaumet

1 May 2014 in Journal of Inorganic Biochemistry
Verified
Journal Article
Closed access
OMOlga Mazuryk
Olga Mazuryk
MMMonika Maciuszek
Monika Maciuszek
GSGrażyna Stochel
Grażyna Stochel
FSFranck Suzenet
Franck Suzenet
MBMałgorzata Brindell
Małgorzata Brindell

Verified
Journal Article
Open access
PDF file
CLCéline Legros
Céline Legros
UMUlrich Matthey
Ulrich Matthey
TGTeresa Grelak
Teresa Grelak
SPSandrine Pedragona-Moreau
Sandrine Pedragona-Moreau
WHWerner Hassler
Werner Hassler
Jean Albert BoutinJean Albert Boutin
Jean Albert Boutin
Melatonin receptors have been studied for several decades. The low expression of the receptors in tissues led the scientific community to find a substitute for the natural hormone melatonin, the agonist 2-[125I]-iodomelatonin. Using the agonist, several hundreds of studies were conducted, including the discovery of agonists and antagonists for the receptors and minute details about their molecular behavior. Recently, we attempted to expand the panel of radioligands available for studying the melatonin receptors by using the newly discovered compounds SD6, DIV880, and S70254. These compounds were characterized for their affinities to the hMT1 and hMT2 recombinant receptors and their functionality in the classical GTPS system. SD6 is a full agonist, equilibrated between the receptor isoforms, whereas S70254 and DIV880 are only partial MT2 agonists, with Ki in the low nanomolar range while they have no affinity to MT1 receptors. These new tools will hopefully allow for additions to the current body of information on the native localization of the receptor isoforms in tissues.

11 June 2019 in Chemical Communications
Verified
Journal Article
Closed access
PDF file
DSDoina Sirbu
Doina Sirbu
JDJulien Diharce
Julien Diharce
IMIvana Martinić
Ivana Martinić
NCNicolas Chopin
Nicolas Chopin
SESvetlana V. Eliseeva
Svetlana V. Eliseeva
FSFranck Suzenet
Franck Suzenet
An unusual class, compact in size, of fluorescent probes based on pyridazino-1,3a,6a-triazapentalene scaffolds exhibits promising fluorescent properties (quantum yield values up to 73%, large Stokes shifts, emission wavelengths located in the green-yellow range, excellent solubility) with good photostability suitable for optical imaging applications.

23 November 2013 in ACS Medicinal Chemistry Letters
Verified
Journal Article
Closed access
JTJérémy Thireau
Jérémy Thireau
JMJustine Marteaux
Justine Marteaux
PDPhilippe Delagrange
Philippe Delagrange
FLFrancois Lefoulon
Francois Lefoulon
LDLaurence Dufourny
Laurence Dufourny
FSFranck Suzenet
Franck Suzenet